National and Kapodistrian University of Athens
Ανοσοϊστοχημική διερεύνηση της έκφρασης p53, Bcl-2, Survivin, EGFR, σε υπερπλαστικές, δυσπλαστικές και καρκινωματώδεις εξεργασίες του παγκρέατος
Abstract
dc:descriptionAim: To examine the expression of the anti-apoptotic factors p53, bd-2, EGFR and survivin in pancreatic ductal adenocarcinomas. Material and Methods: 115 cases of resected pancreatic adenocarcinomas examined at the Pathology Department of Aretaieion University Hospital during a decade (2001-2010) were studied. Additional sections from the archived specimens were obtained and further studied by a Ventana automatic immunohistochemistry method for the expression of p53, bcl-2, EGFR and survivin. The findings were correlated with clinical and pathological data available in all cases. Results: Clinico-Pathological Data: 70 patients were male and 45 were female, with age ranging between 38- 83 years (mean age was 60). Tumors were located mainly in the head of the pancreas (84.3%) and measured 0.5-6.5cm in diameter. Immunohistochemistry: In stage I tumors, out of 22 cases (19.1%), positive immunoreaction was observed in 6 cases for p53, in 15 cases for bcl-2, in 5 cases for EGFR and in 3 cases for survivin. In stage II tumors, out of 44 cases (38.2%), there were 21 positive cases for p53, 13 cases for bcl-2, 16 cases for EGFR and 13 cases for survivin. In stage III tumors, out of 36 cases (31.3%), positive were 24 cases for p53,6 cases for bcl-2, 25 cases for EGFR and 23 cases for survivin. Finally, in stage IV tumors, out of 13 cases (11.3%), positive were 11 cases for p53,3 cases for bcl-2,10 cases for EGFR and 10 cases for survivin. Conclusions: Higher p53, EGFR and survivin expression was noted at higher stages of disease and poorly differentiated tumors and may constitute, and the aforementioned molecules might be markers of poor prognosis while bcl-2 immunoreaction was observed mainly in stage I, well differentiated tumors, and may imply better prognosis.KEY WORDS: Pancreas, Adenocarcinoma, p53, bcl-2, EGFR, Survivin, Prognosis
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Goula, Kallirroi
- Γούλα, Καλλιρρόη
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38159